Canadian VIGOUR Centre
@cvcualberta.bsky.social
The Canadian VIGOUR Centre (CVC) is an academic research organization at the University of Alberta dedicated to enhancing cardiovascular health.
Reposted by Canadian VIGOUR Centre
In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo
@asnkidney.bsky.social | #KidneyWk
@asnkidney.bsky.social | #KidneyWk
November 7, 2025 at 4:36 PM
In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo
@asnkidney.bsky.social | #KidneyWk
@asnkidney.bsky.social | #KidneyWk
Congratulations to CVC Co-Director Dr. Padma Kaul, who has been named Tier 1 Canada Research Chair in Women and Children’s Cardio-Metabolic Health. 👏
www.ualberta.ca/en/the-quad/...
www.ualberta.ca/en/the-quad/...
Meet the U of A's Fall 2025 Canada Research Chairs
www.ualberta.ca
October 31, 2025 at 8:05 PM
Congratulations to CVC Co-Director Dr. Padma Kaul, who has been named Tier 1 Canada Research Chair in Women and Children’s Cardio-Metabolic Health. 👏
www.ualberta.ca/en/the-quad/...
www.ualberta.ca/en/the-quad/...
Reposted by Canadian VIGOUR Centre
In STEMI patients with multivessel disease, reduced LVEF increases ischaemic risk — but the COMPLETE trial showed complete revascularisation reduces major CV events regardless of LVEF. #cardiosky #medsky #LVEF #cardiology
eurointervention.pcronline.com/article/impa...
eurointervention.pcronline.com/article/impa...
October 24, 2025 at 10:17 AM
In STEMI patients with multivessel disease, reduced LVEF increases ischaemic risk — but the COMPLETE trial showed complete revascularisation reduces major CV events regardless of LVEF. #cardiosky #medsky #LVEF #cardiology
eurointervention.pcronline.com/article/impa...
eurointervention.pcronline.com/article/impa...
Reposted by Canadian VIGOUR Centre
🚨 Just published! This guideline provides multi-disciplinary clinical teams with practical recommendations for SGLT2is, MRAs, ARNI and drugs with GLP-1 receptor agonist activity.
Read the guideline here: onlinecjc.ca/article/S082...
#Cardiosky #HeartFailure
Read the guideline here: onlinecjc.ca/article/S082...
#Cardiosky #HeartFailure
October 20, 2025 at 2:00 PM
🚨 Just published! This guideline provides multi-disciplinary clinical teams with practical recommendations for SGLT2is, MRAs, ARNI and drugs with GLP-1 receptor agonist activity.
Read the guideline here: onlinecjc.ca/article/S082...
#Cardiosky #HeartFailure
Read the guideline here: onlinecjc.ca/article/S082...
#Cardiosky #HeartFailure
Reposted by Canadian VIGOUR Centre
At #HFSA2025, we spoke with Justin Ezekowitz, MD, co-director of the Canadian VIGOUR Center, to discuss his analysis of background therapies in the VICTOR trial of vericiguat in HFrEF.
Watch now:
Watch now:
Vericiguat Improves HFrEF Regardless of Background Therapy, With Justin Ezekowitz, MD | HCPLive
Ezekowitz spotlights improvement in cardiovascular mortality and heart failure hospitalization despite a failure to achieve the primary endpoint of VICTOR.
www.hcplive.com
October 18, 2025 at 2:00 PM
At #HFSA2025, we spoke with Justin Ezekowitz, MD, co-director of the Canadian VIGOUR Center, to discuss his analysis of background therapies in the VICTOR trial of vericiguat in HFrEF.
Watch now:
Watch now:
❣️The Fall 2025 issue of the CVC Chronicle newsletter is now available❣️
Read about our current trials, research highlights, & other recent news/updates here: tinyurl.com/3w4srx67
Read about our current trials, research highlights, & other recent news/updates here: tinyurl.com/3w4srx67
October 8, 2025 at 4:34 PM
❣️The Fall 2025 issue of the CVC Chronicle newsletter is now available❣️
Read about our current trials, research highlights, & other recent news/updates here: tinyurl.com/3w4srx67
Read about our current trials, research highlights, & other recent news/updates here: tinyurl.com/3w4srx67
Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, & C-section, highlighting the need for improved asthma monitoring & management during pregnancy. @wchriuofa.bsky.social @stollerykids.bsky.social @ualberta.bsky.social
Maternal asthma a risk for babies, study shows
A University of Alberta-led research team has identified an association between asthma in pregnant women and adverse outcomes for their newborns, including preterm birth, low birth weight and caesarea...
www.ualberta.ca
October 6, 2025 at 4:23 PM
Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, & C-section, highlighting the need for improved asthma monitoring & management during pregnancy. @wchriuofa.bsky.social @stollerykids.bsky.social @ualberta.bsky.social
Reposted by Canadian VIGOUR Centre
Dr. Moorthy reviewing the WHO global action plan for clinical trial ecosystem strengthening at the 4th Annual ACT meeting in Cape Breton, NS. We are making progress in Canada but lots of work to do!
@cvcualberta.bsky.social @csnscn.bsky.social @ualberta.bsky.social
@cvcualberta.bsky.social @csnscn.bsky.social @ualberta.bsky.social
September 25, 2025 at 12:04 PM
Dr. Moorthy reviewing the WHO global action plan for clinical trial ecosystem strengthening at the 4th Annual ACT meeting in Cape Breton, NS. We are making progress in Canada but lots of work to do!
@cvcualberta.bsky.social @csnscn.bsky.social @ualberta.bsky.social
@cvcualberta.bsky.social @csnscn.bsky.social @ualberta.bsky.social
New analysis published in @jcardfail.bsky.social: applying the 5-STAR risk stratification method to VICTORIA trial data revealed a greater treatment effect for vericiguat on the composite endpoint of CV death or HF hospitalization.
Read more ➡️: authors.elsevier.com/a/1llYy3pkRz...
Read more ➡️: authors.elsevier.com/a/1llYy3pkRz...
September 18, 2025 at 4:32 PM
New analysis published in @jcardfail.bsky.social: applying the 5-STAR risk stratification method to VICTORIA trial data revealed a greater treatment effect for vericiguat on the composite endpoint of CV death or HF hospitalization.
Read more ➡️: authors.elsevier.com/a/1llYy3pkRz...
Read more ➡️: authors.elsevier.com/a/1llYy3pkRz...
Reposted by Canadian VIGOUR Centre
Happy to have had the chance to contribute to this amazing collaborative work led by @sandeepsahaymd.bsky.social and Dr Ray Benza
📢 A NEW #ISHLT Consensus Statement on risk stratification in pulmonary arterial hypertension (#PAH) is now available. Check out the top 5️⃣ takeaways ⏬ & read the publication at 🔗 bit.ly/4lXTrLd
September 6, 2025 at 2:48 AM
Happy to have had the chance to contribute to this amazing collaborative work led by @sandeepsahaymd.bsky.social and Dr Ray Benza
Reposted by Canadian VIGOUR Centre
Heart failure affects more than 55 million people worldwide. 🫀
A new Lancet Series, presented at #ESC2025, serves as a call to action for clinicians, health systems, and governments to prioritise the primary prevention of heart failure. tinyurl.com/2sty9386
A new Lancet Series, presented at #ESC2025, serves as a call to action for clinicians, health systems, and governments to prioritise the primary prevention of heart failure. tinyurl.com/2sty9386
August 29, 2025 at 11:46 AM
Heart failure affects more than 55 million people worldwide. 🫀
A new Lancet Series, presented at #ESC2025, serves as a call to action for clinicians, health systems, and governments to prioritise the primary prevention of heart failure. tinyurl.com/2sty9386
A new Lancet Series, presented at #ESC2025, serves as a call to action for clinicians, health systems, and governments to prioritise the primary prevention of heart failure. tinyurl.com/2sty9386
Reposted by Canadian VIGOUR Centre
Late-breaking science from VICTOR & VICTORIA trials presented at #ESCCongress add to growing body of evidence surrounding vericiguat in treating patients with HFrEF. Read more: https://bit.ly/4lTUNXE
#HeartFailure
#HeartFailure
August 30, 2025 at 12:50 PM
Late-breaking science from VICTOR & VICTORIA trials presented at #ESCCongress add to growing body of evidence surrounding vericiguat in treating patients with HFrEF. Read more: https://bit.ly/4lTUNXE
#HeartFailure
#HeartFailure
Reposted by Canadian VIGOUR Centre
In #HFrEF, quadruple therapy (ARNi, β-blockers, MRA, #SGLT2i) improves survival. Adding #vericiguat may offer a modest ~0.7-year gain, though findings are exploratory, as they are derived from a secondary endpoint of a single trial https://bit.ly/4mE83Rp
#JACC #ESCCongress #WCCardio
#JACC #ESCCongress #WCCardio
August 30, 2025 at 6:35 AM
In #HFrEF, quadruple therapy (ARNi, β-blockers, MRA, #SGLT2i) improves survival. Adding #vericiguat may offer a modest ~0.7-year gain, though findings are exploratory, as they are derived from a secondary endpoint of a single trial https://bit.ly/4mE83Rp
#JACC #ESCCongress #WCCardio
#JACC #ESCCongress #WCCardio
The AURORA study is currently recruiting adults & adolescents with type 1 diabetes (T1D) & caregivers for an advisory group. Share your experience navigating the Alberta healthcare system & help us create a vital T1D knowledge hub!
Learn more ➡️: thecvc.ca/aurora-recru...
Learn more ➡️: thecvc.ca/aurora-recru...
August 21, 2025 at 7:48 PM
The AURORA study is currently recruiting adults & adolescents with type 1 diabetes (T1D) & caregivers for an advisory group. Share your experience navigating the Alberta healthcare system & help us create a vital T1D knowledge hub!
Learn more ➡️: thecvc.ca/aurora-recru...
Learn more ➡️: thecvc.ca/aurora-recru...
Reposted by Canadian VIGOUR Centre
Excited to finally share our
James Lind Alliance
#Top10 Research Priorities for #LungTransplantation 🫁🔬👩🏽🔬
@ualberta.bsky.social
@ubcmedicine.bsky.social
@umontreal.ca @uhnresearch.ca @ucalgarymed.bsky.social
www.jhltopen.org/article/S295...
James Lind Alliance
#Top10 Research Priorities for #LungTransplantation 🫁🔬👩🏽🔬
@ualberta.bsky.social
@ubcmedicine.bsky.social
@umontreal.ca @uhnresearch.ca @ucalgarymed.bsky.social
www.jhltopen.org/article/S295...
Priorities for lung transplantation research: a James Lind Alliance priority-setting partnership between patients, caregivers, and clinicians in Canada
This study employed the James Lind Alliance Priority Setting Partnership methodology
to identify and prioritize research priorities in lung transplantation through engagement
of pre- and post-lung tra...
www.jhltopen.org
August 5, 2025 at 1:59 PM
Excited to finally share our
James Lind Alliance
#Top10 Research Priorities for #LungTransplantation 🫁🔬👩🏽🔬
@ualberta.bsky.social
@ubcmedicine.bsky.social
@umontreal.ca @uhnresearch.ca @ucalgarymed.bsky.social
www.jhltopen.org/article/S295...
James Lind Alliance
#Top10 Research Priorities for #LungTransplantation 🫁🔬👩🏽🔬
@ualberta.bsky.social
@ubcmedicine.bsky.social
@umontreal.ca @uhnresearch.ca @ucalgarymed.bsky.social
www.jhltopen.org/article/S295...
Reposted by Canadian VIGOUR Centre
Patients hospitalized with influenza are just as likely as COVID-19 patients to have signs of myocardial involvement. Lead study author Finlay McAlister said the findings show a need to screen and monitor patients more closely. www.tctmd.com/news/cardiac...
Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza
Patients who are hospitalized for either viral infection should be screened for myocardial involvement, experts say.
www.tctmd.com
August 2, 2025 at 1:30 PM
Patients hospitalized with influenza are just as likely as COVID-19 patients to have signs of myocardial involvement. Lead study author Finlay McAlister said the findings show a need to screen and monitor patients more closely. www.tctmd.com/news/cardiac...
New in @jaccjournals.bsky.social: A secondary analysis of the VICTORIA trial investigates the impact of geographic variation and Human Development Index on heart failure outcomes. 🫀 🌏
Read more here: www.sciencedirect.com/science/arti...
Read more here: www.sciencedirect.com/science/arti...
July 15, 2025 at 5:51 PM
New in @jaccjournals.bsky.social: A secondary analysis of the VICTORIA trial investigates the impact of geographic variation and Human Development Index on heart failure outcomes. 🫀 🌏
Read more here: www.sciencedirect.com/science/arti...
Read more here: www.sciencedirect.com/science/arti...
Reposted by Canadian VIGOUR Centre
💭 Review of transcatheter aortic valve insertion (#TAVI) clinician opinions on the CCS Post-TAVI Driving Guidelines: is a 1-month driving restriction period overly cautious? Read more ⬇️
cjcopen.ca/article/S258...
#CJCO #OpenAccess
cjcopen.ca/article/S258...
#CJCO #OpenAccess
June 25, 2025 at 5:21 PM
💭 Review of transcatheter aortic valve insertion (#TAVI) clinician opinions on the CCS Post-TAVI Driving Guidelines: is a 1-month driving restriction period overly cautious? Read more ⬇️
cjcopen.ca/article/S258...
#CJCO #OpenAccess
cjcopen.ca/article/S258...
#CJCO #OpenAccess
Reposted by Canadian VIGOUR Centre
Among patients with opioid-associated out-of-hospital cardiac arrest, chest compression and ventilation CPR was associated with a higher odds of favorable neurologic outcomes at hospital discharge.
ja.ma/4l7We4q
ja.ma/4l7We4q
June 17, 2025 at 4:43 PM
Among patients with opioid-associated out-of-hospital cardiac arrest, chest compression and ventilation CPR was associated with a higher odds of favorable neurologic outcomes at hospital discharge.
ja.ma/4l7We4q
ja.ma/4l7We4q
Reposted by Canadian VIGOUR Centre
Dr. Jason Weatherald explains how your everyday clinic visits can help shape the future of pulmonary hypertension treatment. @phaware.bsky.social podcast ep 524 @phacanada #phawareMD @teamphhope @albertaphdoc.bsky.social @ualberta.bsky.social medium.com/p/im-aware-t...
I’m Aware That I’m Rare: Jason Weatherald, MD (524)
the phaware® interview
medium.com
June 10, 2025 at 1:22 PM
Dr. Jason Weatherald explains how your everyday clinic visits can help shape the future of pulmonary hypertension treatment. @phaware.bsky.social podcast ep 524 @phacanada #phawareMD @teamphhope @albertaphdoc.bsky.social @ualberta.bsky.social medium.com/p/im-aware-t...
Reposted by Canadian VIGOUR Centre
🫀 Join us June 11 for our webinar: Heart-Healthy Eating: Evidence-Based Nutrition for Cardiovascular Health!
🔗 Register now! ow.ly/yBOO50W5aZP
#cardiosky
🔗 Register now! ow.ly/yBOO50W5aZP
#cardiosky
June 5, 2025 at 8:53 PM
🫀 Join us June 11 for our webinar: Heart-Healthy Eating: Evidence-Based Nutrition for Cardiovascular Health!
🔗 Register now! ow.ly/yBOO50W5aZP
#cardiosky
🔗 Register now! ow.ly/yBOO50W5aZP
#cardiosky
Dr. Padma Kaul will lead a #OneChildEveryChild program exploring how clinical, genetic, socio-economic, & behavioral factors impact neonatal & early childhood outcomes following pregnancy complications. @wchriuofa.bsky.social
Read more about the OCEC initiative ⬇️
www.ucalgary.ca/news/ucalgar...
Read more about the OCEC initiative ⬇️
www.ucalgary.ca/news/ucalgar...
UCalgary experts investigate effects of climate change on child health, and possible solutions
Transdisciplinary project one of six research programs announced by One Child Every Child initiative
www.ucalgary.ca
May 23, 2025 at 2:57 PM
Dr. Padma Kaul will lead a #OneChildEveryChild program exploring how clinical, genetic, socio-economic, & behavioral factors impact neonatal & early childhood outcomes following pregnancy complications. @wchriuofa.bsky.social
Read more about the OCEC initiative ⬇️
www.ucalgary.ca/news/ucalgar...
Read more about the OCEC initiative ⬇️
www.ucalgary.ca/news/ucalgar...
❣️The Spring 2025 issue of the CVC Chronicle newsletter is now available ❣️
Read about our current trials, research highlights, & other recent news/updates here: mailchi.mp/3fed258d1c05...
Read about our current trials, research highlights, & other recent news/updates here: mailchi.mp/3fed258d1c05...
May 15, 2025 at 6:20 PM
❣️The Spring 2025 issue of the CVC Chronicle newsletter is now available ❣️
Read about our current trials, research highlights, & other recent news/updates here: mailchi.mp/3fed258d1c05...
Read about our current trials, research highlights, & other recent news/updates here: mailchi.mp/3fed258d1c05...
New research: Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, & C-section. These findings highlight the need for improved asthma monitoring & management during pregnancy. @wchriuofa.bsky.social
Read here: www.sciencedirect.com/science/arti...
Read here: www.sciencedirect.com/science/arti...
May 13, 2025 at 5:29 PM
New research: Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, & C-section. These findings highlight the need for improved asthma monitoring & management during pregnancy. @wchriuofa.bsky.social
Read here: www.sciencedirect.com/science/arti...
Read here: www.sciencedirect.com/science/arti...
Featured CJC Open article from CVC authors highlights the substantial and likely rising cost of heart failure hospitalizations in Canada, underscoring the urgent need for strategic solutions.
Read here ▶️: www.cjcopen.ca/article/S258...
#HeartFailureWeekCan
Read here ▶️: www.cjcopen.ca/article/S258...
#HeartFailureWeekCan
Looking for resources in honour of Heart Failure Awareness Week 2025? Don’t miss our curated collection of articles from CCS Journals available here: ccs.ca/wp-content/u...
May 8, 2025 at 9:47 PM
Featured CJC Open article from CVC authors highlights the substantial and likely rising cost of heart failure hospitalizations in Canada, underscoring the urgent need for strategic solutions.
Read here ▶️: www.cjcopen.ca/article/S258...
#HeartFailureWeekCan
Read here ▶️: www.cjcopen.ca/article/S258...
#HeartFailureWeekCan